Multiple Dose Safety, Tolerability, Plasma and Cerebrospinal-Fluid Pharmacokinetic Study of Oral Doses of CORT113176
Latest Information Update: 12 Oct 2021
At a glance
- Drugs Dazucorilant (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- Sponsors Corcept Therapeutics
- 07 Oct 2021 Status changed from recruiting to completed.
- 12 Aug 2021 New trial record